Sector Gamma As Buys Bristol-Myers Squibb Company, Perrigo Co PLC, Abbott Laboratories, Sells Merck Inc, Exelixis Inc, Alexion Pharmaceuticals Inc

• New Purchases: PRGO, LH, LXRX,
• Added Positions: BMY, ABT, ANTM, GILD, SHPG, BAX, BSX, IPXL,
• Reduced Positions: UTHR, VRTX, MASI, IART, OMI, CI, MNTA, IRWD,
• Sold Out: MRK, EXEL, ALXN,

For the details of SECTOR GAMMA AS's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=SECTOR+GAMMA+AS

1. Abbott Laboratories (ABT) - 1,318,642 shares, 9.31% of the total portfolio. Shares added by 35.03%
2. Eli Lilly and Co (LLY) - 661,350 shares, 8.85% of the total portfolio. Shares reduced by 0.85%
3. Baxter International Inc (BAX) - 1,036,233 shares, 8.55% of the total portfolio. Shares added by 8.75%
4. Bristol-Myers Squibb Company (BMY) - 782,390 shares, 6.77% of the total portfolio. Shares added by 74.14%
5. PerkinElmer Inc (PKI) - 623,408 shares, 5.76% of the total portfolio.

Sector Gamma As initiated holdings in Perrigo Co PLC. The purchase prices were between $66.39 and $87.23, with an estimated average price of $76.04. The stock is now traded at around $71.22. The impact to the portfolio due to this purchase was 2.61%. The holdings were 247,340 shares as of 2017-03-31.

Sector Gamma As initiated holdings in Laboratory Corp of America Holdings. The purchase prices were between $129.07 and $144.27, with an estimated average price of $137.82. The stock is now traded at around $139.87. The impact to the portfolio due to this purchase was 1.91%. The holdings were 83,900 shares as of 2017-03-31.

Sector Gamma As initiated holdings in Lexicon Pharmaceuticals Inc. The purchase prices were between $13.68 and $16.73, with an estimated average price of $14.84. The stock is now traded at around $15.36. The impact to the portfolio due to this purchase was 0.76%. The holdings were 332,300 shares as of 2017-03-31.

Sector Gamma As added to the holdings in Bristol-Myers Squibb Company by 74.14%. The purchase prices were between $46.82 and $60.13, with an estimated average price of $54.85. The stock is now traded at around $52.85. The impact to the portfolio due to this purchase was 2.88%. The holdings were 782,390 shares as of 2017-03-31.

Sector Gamma As added to the holdings in Abbott Laboratories by 35.03%. The purchase prices were between $39.05 and $45.72, with an estimated average price of $43.23. The stock is now traded at around $46.72. The impact to the portfolio due to this purchase was 2.41%. The holdings were 1,318,642 shares as of 2017-03-31.

Sector Gamma As added to the holdings in Anthem Inc by 45.31%. The purchase prices were between $142.79 and $169.2, with an estimated average price of $159.07. The stock is now traded at around $187.59. The impact to the portfolio due to this purchase was 1.68%. The holdings were 204,610 shares as of 2017-03-31.

Sector Gamma As added to the holdings in Gilead Sciences Inc by 24.83%. The purchase prices were between $65.59 and $76.38, with an estimated average price of $70.32. The stock is now traded at around $64.12. The impact to the portfolio due to this purchase was 0.96%. The holdings were 448,490 shares as of 2017-03-31.

Sector Gamma As added to the holdings in Shire PLC by 23.00%. The purchase prices were between $161.71 and $186.3, with an estimated average price of $174.68. The stock is now traded at around $167.83. The impact to the portfolio due to this purchase was 0.94%. The holdings were 180,761 shares as of 2017-03-31.

Sector Gamma As sold out the holdings in Merck & Co Inc. The sale prices were between $59.92 and $66.58, with an estimated average price of $63.58.

Sector Gamma As sold out the holdings in Exelixis Inc. The sale prices were between $14.73 and $23.12, with an estimated average price of $20.34.

Sector Gamma As sold out the holdings in Alexion Pharmaceuticals Inc. The sale prices were between $118.53 and $144.77, with an estimated average price of $128.92.